232 related articles for article (PubMed ID: 18196535)
1. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
Sroka IC; McDaniel K; Nagle RB; Bowden GT
Prostate; 2008 Apr; 68(5):463-76. PubMed ID: 18196535
[TBL] [Abstract][Full Text] [Related]
2. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
Upadhyay J; Shekarriz B; Nemeth JA; Dong Z; Cummings GD; Fridman R; Sakr W; Grignon DJ; Cher ML
Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
[TBL] [Abstract][Full Text] [Related]
3. Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells.
Armakolas A; Philippou A; Panteleakou Z; Nezos A; Sourla A; Petraki C; Koutsilieris M
Prostate; 2010 Aug; 70(11):1233-42. PubMed ID: 20564425
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
5. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer.
Liao X; Thrasher JB; Pelling J; Holzbeierlein J; Sang QX; Li B
Endocrinology; 2003 May; 144(5):1656-63. PubMed ID: 12697668
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
8. The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.
Bratland A; Ragnhildstveit E; Bjørnland K; Andersen K; Maelandsmo GM; Fodstad O; Saatcioglu F; Ree AH
Clin Exp Metastasis; 2003; 20(6):541-7. PubMed ID: 14598888
[TBL] [Abstract][Full Text] [Related]
9. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
10. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.
Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T
Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of potential therapeutic targets in prostate cancer.
Zellweger T; Ninck C; Bloch M; Mirlacher M; Koivisto PA; Helin HJ; Mihatsch MJ; Gasser TC; Bubendorf L
Int J Cancer; 2005 Feb; 113(4):619-28. PubMed ID: 15472903
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
13. Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells.
Sroka IC; Nagle RB; Bowden GT
Neoplasia; 2007 May; 9(5):406-17. PubMed ID: 17534446
[TBL] [Abstract][Full Text] [Related]
14. Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis.
Cao J; Chiarelli C; Kozarekar P; Adler HL
Thromb Haemost; 2005 Apr; 93(4):770-8. PubMed ID: 15841326
[TBL] [Abstract][Full Text] [Related]
15. Increased aggressiveness of human prostate PC-3 tumor cells expressing cell surface localized membrane type-1 matrix metalloproteinase (MT1-MMP).
Wang X; Wilson MJ; Slaton JW; Sinha AA; Ewing SL; Pei D
J Androl; 2009; 30(3):259-74. PubMed ID: 19136391
[TBL] [Abstract][Full Text] [Related]
16. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
[TBL] [Abstract][Full Text] [Related]
17. Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.
Ma Y; Cheng Q; Ren Z; Xu L; Zhao Y; Sun J; Hu S; Xiao W
Cancer Lett; 2012 Apr; 317(2):150-6. PubMed ID: 22115966
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
Hong H; Kao C; Jeng MH; Eble JN; Koch MO; Gardner TA; Zhang S; Li L; Pan CX; Hu Z; MacLennan GT; Cheng L
Cancer; 2004 Jul; 101(1):83-9. PubMed ID: 15221992
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.
Bonfil RD; Dong Z; Trindade Filho JC; Sabbota A; Osenkowski P; Nabha S; Yamamoto H; Chinni SR; Zhao H; Mobashery S; Vessella RL; Fridman R; Cher ML
Am J Pathol; 2007 Jun; 170(6):2100-11. PubMed ID: 17525276
[TBL] [Abstract][Full Text] [Related]
20. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
